During the past decade, The Birmingham Pain Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 1 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "The Birmingham Pain Center" #1 collaborator was "Sucampo Pharmaceuticals, Inc." with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "The Birmingham Pain Center" are "Chronic Pain" (3 trials), "Back Pain Lower Back Chronic" (2 trials), "Opioid-Induced Bowel Dysfunction" (2 trials), "Osteoarthritis" (2 trials) and "Breakthrough Pain" (1 trials). Many other conditions were trialed in "The Birmingham Pain Center" in a lesser frequency.

Most popular intervention types in "The Birmingham Pain Center" are "Drug" (8 trials). Other intervention types were less common.

The name of intervention was led by "Buprenorphine transdermal patch" (2 trials), "Placebo" (2 trials), "ALO-01 (Morphine Sulfate Plus Naltrexone Hydrochloride Extended Release)" (1 trials), "Buprenorphine" (1 trials) and "Fentanyl Buccal Tablets" (1 trials). Other intervention names were less common.

The vast majority of trials in "The Birmingham Pain Center" are 8 trials for "All" genders.

Currently, there are NaN active trials in "The Birmingham Pain Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in The Birmingham Pain Center, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in The Birmingham Pain Center, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 8 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".